Skip to main content
Article
Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID-19 Treatment (Part I)
LinkedIn
  • Qing Liu
  • Karl E. Peace, Georgia Southern University
Document Type
Article
Publication Date
5-10-2020
Abstract

Part I of the article that describes confirmatory adaptive platform trial (CAPT) design for COVID-19 treatment development. In the Introduction, we provide generate description of ACTT, CATCO and SOLIDARITY trials which are emerging as confirmatory trials. We then describe key elements of CAPT design, followed by legal and regulatory requirement for confirmatory trial designs.

Citation Information
Qing Liu and Karl E. Peace. "Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID-19 Treatment (Part I)" LinkedIn (2020)
Available at: http://works.bepress.com/karl_peace/374/